A muscarinic receptor antagonist drug used for treating contraction of overactive bladder such as incontinence, urinary frequency, and urgency. Solifenacin is a competitive cholinergic receptor antagonist, selective for the M3 receptor subtype. It was manufactured and marketed by Astellas, GlaxoSmithKline and Teva Pharmaceutical Industries.[ Reference standards of Solifenacin Succinate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Solifenacin Nitroso Impurity [catalogue_number] => PA 19 0501012 [category_ids] => ,70,75,76,78,82,162, [chemical_name] => [weight] => 238.29 [form] => C15H14N2O [cas] => NA [pslug] => solifenacin-nitroso-impurity-pa190501012 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 19 0501012
CAS :
Molecular Formula : C15H14N2O
Molecular Weight : 238.29
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
